<?xml version="1.0" encoding="UTF-8"?>
<p>Toxicity: The LD
 <sub>50</sub> of orally administered 
 <italic>Bacopa</italic> extracts in rats was 5 g/kg for aqueous extract and 17 g/kg of the alcoholic extract [
 <xref rid="B77-brainsci-10-00964" ref-type="bibr">77</xref>]. The intraperitoneal LD
 <sub>50</sub> was 1000 mg/kg for aqueous extract and 15 g/kg for alcoholic extract [
 <xref rid="B94-brainsci-10-00964" ref-type="bibr">94</xref>]. A double-blind, placebo-controlled trial in healthy male volunteers reported safety and tolerability of bacosides in single (20–30 mg) and multiple (100–200 mg) daily doses over a four-week period [
 <xref rid="B77-brainsci-10-00964" ref-type="bibr">77</xref>]. A randomized, double-blind, placebo-controlled trial reported that 
 <italic>Bacopa</italic> treatment (300 mg/kg, daily) for 12 weeks caused increased stool frequency, abdominal cramps and nausea, which may be due to either an upregulation of ACh level or saponin-mediated gastrointestinal tract irritation, or both [
 <xref rid="B91-brainsci-10-00964" ref-type="bibr">91</xref>].
</p>
